Global Infection Prevention & Control Market Outlook (2018 to 2027) - Featuring 3M, Baxter International & Ansell Among Others -

DUBLIN--()--The "Infection Prevention & Control - Global Market Outlook (2018-2027)" report has been added to's offering.

The Global Infection Prevention & Control market accounted for $139.59 billion in 2018 and is expected to reach $224.08 billion by 2027 growing at a CAGR of 5.4% during the forecast period.

Some of the key factors propelling the market growth include increased adoption of contract sterilization and in-house sterilization procedures, increase in incidence of hospital acquired infections (HAIS), growing number of surgical procedures, rising number of government initiatives, and rapidly growing geriatric population. However, low level of vaccination among healthcare workers is likely to hamper the market.

Infection prevention and control is the most important and significant step in the development and maintenance of products in the medical devices, pharmaceuticals, and food industries. It is to prevent the transmission of communicable disease. For the prevention of any infection one should have the basic understanding of the infection and the risk of the infection. Infection prevention and control system includes the necessary products to prevent the cross infection from equipment, surface and skin of patient and healthcare staff.

By products & services equipment, the personal protective equipment segment is anticipated to grow at a significant rate during the forecast period. With the growth in prevention and control concerns of various health associated infections, personal protective equipment's. To control various types of cross-infections in hospitals and clinics also there has been a growth of personal protective equipment's market globally. Demand for better quality care in hospitals and other healthcare establishments is forcing the hospitals to invest in quality medical protective wear and other accessories has also acted as a key factor in the growth of this segment.

On the basis of geography, North America region is anticipated to have considerable market growth during the forecast period, due to rising prevalence of the nosocomial infection and stringent regulation followed by the hospitals, clinicians and care givers aligning with regulatory bodies. With the increase in the number of death due to Antibiotic-resistant infections, by contrast it is anticipated that there will be a growth in IP&C Market in the regions of North America.

Companies Mentioned

  • Danaher Corporation
  • Johnson & Johnson
  • Becton, Dickinson, and Company
  • 3M Company
  • Baxter International
  • Ansell Limited
  • Belimed AG
  • Aquionics
  • Bemis Company Incorporated
  • Abbott
  • Braun (B.) Melsungen AG
  • Cantel Medical Corporation
  • Cardinal Health Incorporated
  • Covidien
  • Henkel
  • Simens
  • Getinge Group
  • Hollister
  • Medtronics
  • CCP Industries

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Key Topics Covered:

1 Executive Summary

2 Preface

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 End User Analysis

3.7 Emerging Markets

3.8 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Infection Prevention & Control Market, By Antimicrobial Drugs

5.1 Introduction

5.2 Anti-Fungal Drugs

5.3 Vaccines

5.4 Anti-Bacterial Drugs

5.5 Anti-Viral Drugs

6 Global Infection Prevention & Control Market, By Infection Type

6.1 Introduction

6.2 Healthcare Associated Infections

6.3 Microbial infections

7 Global Infection Prevention & Control Market, By Products & Services Equipment

7.1 Introduction

7.2 Infection Prevention Supplies

7.3 Infection Prevention Equipment

8 Global Infection Prevention & Control Market, By End User

8.1 Introduction

8.2 Drug Usage

8.3 Equipment Usage

9 Global Infection Prevention & Control Market, By Geography

9.1 Introduction

9.2 North America

9.3 Europe

9.4 Asia Pacific

9.5 South America

9.6 Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures

10.2 Acquisitions & Mergers

10.3 New Product Launch

10.4 Expansions

10.5 Other Key Strategies

11 Company Profiling

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900